辽宁完善短缺药品供应保障

2017-10-11 阎红 健康报

近日,辽宁省卫生计生委、辽宁省工业和信息化委等10部门联合印发《关于改革完善短缺药品供应保障机制的实施意见》提出,采取7个方面举措,完善短缺药品供应保障机制。

近日,辽宁省卫生计生委、辽宁省工业和信息化委等10部门联合印发《关于改革完善短缺药品供应保障机制的实施意见》提出,采取7个方面举措,完善短缺药品供应保障机制。

《意见》要求:

一 完善辽宁省短缺药品监测预警和供应保障信息系统功能,建立辽宁省短缺药品信息库,实行动态管理

二 完善短缺药品监测网络体系和预警机制,实行药品生产企业药品短缺预警报告制度,实行药品经营企业药品短缺监测预警报告制度,实行医疗卫生机构短缺药品信息直报制度。

三 完善短缺药品清单管理和预警预报制度,根据短缺原因、短缺程度、影响范围等情况,及时启动省、市、县三级应对机制,定期发布《辽宁省短缺药品预警预报》。

四 探索建立智库优化用药指导制度,建立辽宁省短缺药品会商指导专家库,开展替代药品综合评价,探索建立和完善药物临床评价体系,组织开展清单内药品临床综合评价,为医疗卫生机构和患者提供临床用药指导。

五 建立短缺药品供应保障分级联动应对机制,联动会商机制办公室设在辽宁省卫生计生委,负责短缺药品综合协调、监测预警,综合评估辖区内药品短缺信息和应对建议。重点强化省、市、县三级监测,及时分析、处理、上报短缺信息,增强综合应对能力。

六 实行短缺药品供应保障分类精准施策。

七 强化药品供应保障政策联动。

该省要求,规范药品购销秩序,督促购销双方依法签订合同并严格履行。对违反合同约定,配送不及时影响临床用药或拒绝提供偏远地区配送服务的企业,逾期不改正的,取消该企业参与辽宁省医疗机构药品集中采购资格,记入药品采购不良记录并向社会公布,公立医疗卫生机构两年内不得采购其药品。要将药品采购按期回款情况作为公立医疗卫生机构年度考核和院长年终考评的重要内容。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1800932, encodeId=a12118009324a, content=<a href='/topic/show?id=f59ce3244d2' target=_blank style='color:#2F92EE;'>#短缺药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73244, encryptionId=f59ce3244d2, topicName=短缺药品供应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Dec 05 23:34:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716324, encodeId=704f1e16324b4, content=<a href='/topic/show?id=c0a18e35889' target=_blank style='color:#2F92EE;'>#药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87358, encryptionId=c0a18e35889, topicName=药品供应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c5232213503, createdName=yyanpro@32cn.c, createdTime=Tue Aug 14 22:34:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028719, encodeId=32f92028e19b3, content=<a href='/topic/show?id=dba72683e0b' target=_blank style='color:#2F92EE;'>#供应保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26837, encryptionId=dba72683e0b, topicName=供应保障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Sun Aug 19 00:34:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536325, encodeId=299c15363259e, content=<a href='/topic/show?id=ae8fe324387' target=_blank style='color:#2F92EE;'>#短缺药品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73243, encryptionId=ae8fe324387, topicName=短缺药品)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c7712689228, createdName=chaojitidian, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618007, encodeId=88b0161800e1f, content=<a href='/topic/show?id=c103e3239e8' target=_blank style='color:#2F92EE;'>#短缺药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73239, encryptionId=c103e3239e8, topicName=短缺药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1719824693, createdName=passed water, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628092, encodeId=2972162809271, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251982, encodeId=31c725198281, content=好啊后, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed Oct 11 16:45:04 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251958, encodeId=38dd2519589a, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Oct 11 14:08:06 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251927, encodeId=f6d025192e9b, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Wed Oct 11 13:14:53 CST 2017, time=2017-10-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1800932, encodeId=a12118009324a, content=<a href='/topic/show?id=f59ce3244d2' target=_blank style='color:#2F92EE;'>#短缺药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73244, encryptionId=f59ce3244d2, topicName=短缺药品供应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Dec 05 23:34:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716324, encodeId=704f1e16324b4, content=<a href='/topic/show?id=c0a18e35889' target=_blank style='color:#2F92EE;'>#药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87358, encryptionId=c0a18e35889, topicName=药品供应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c5232213503, createdName=yyanpro@32cn.c, createdTime=Tue Aug 14 22:34:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028719, encodeId=32f92028e19b3, content=<a href='/topic/show?id=dba72683e0b' target=_blank style='color:#2F92EE;'>#供应保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26837, encryptionId=dba72683e0b, topicName=供应保障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Sun Aug 19 00:34:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536325, encodeId=299c15363259e, content=<a href='/topic/show?id=ae8fe324387' target=_blank style='color:#2F92EE;'>#短缺药品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73243, encryptionId=ae8fe324387, topicName=短缺药品)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c7712689228, createdName=chaojitidian, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618007, encodeId=88b0161800e1f, content=<a href='/topic/show?id=c103e3239e8' target=_blank style='color:#2F92EE;'>#短缺药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73239, encryptionId=c103e3239e8, topicName=短缺药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1719824693, createdName=passed water, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628092, encodeId=2972162809271, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251982, encodeId=31c725198281, content=好啊后, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed Oct 11 16:45:04 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251958, encodeId=38dd2519589a, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Oct 11 14:08:06 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251927, encodeId=f6d025192e9b, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Wed Oct 11 13:14:53 CST 2017, time=2017-10-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1800932, encodeId=a12118009324a, content=<a href='/topic/show?id=f59ce3244d2' target=_blank style='color:#2F92EE;'>#短缺药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73244, encryptionId=f59ce3244d2, topicName=短缺药品供应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Dec 05 23:34:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716324, encodeId=704f1e16324b4, content=<a href='/topic/show?id=c0a18e35889' target=_blank style='color:#2F92EE;'>#药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87358, encryptionId=c0a18e35889, topicName=药品供应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c5232213503, createdName=yyanpro@32cn.c, createdTime=Tue Aug 14 22:34:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028719, encodeId=32f92028e19b3, content=<a href='/topic/show?id=dba72683e0b' target=_blank style='color:#2F92EE;'>#供应保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26837, encryptionId=dba72683e0b, topicName=供应保障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Sun Aug 19 00:34:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536325, encodeId=299c15363259e, content=<a href='/topic/show?id=ae8fe324387' target=_blank style='color:#2F92EE;'>#短缺药品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73243, encryptionId=ae8fe324387, topicName=短缺药品)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c7712689228, createdName=chaojitidian, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618007, encodeId=88b0161800e1f, content=<a href='/topic/show?id=c103e3239e8' target=_blank style='color:#2F92EE;'>#短缺药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73239, encryptionId=c103e3239e8, topicName=短缺药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1719824693, createdName=passed water, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628092, encodeId=2972162809271, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251982, encodeId=31c725198281, content=好啊后, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed Oct 11 16:45:04 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251958, encodeId=38dd2519589a, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Oct 11 14:08:06 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251927, encodeId=f6d025192e9b, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Wed Oct 11 13:14:53 CST 2017, time=2017-10-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1800932, encodeId=a12118009324a, content=<a href='/topic/show?id=f59ce3244d2' target=_blank style='color:#2F92EE;'>#短缺药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73244, encryptionId=f59ce3244d2, topicName=短缺药品供应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Dec 05 23:34:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716324, encodeId=704f1e16324b4, content=<a href='/topic/show?id=c0a18e35889' target=_blank style='color:#2F92EE;'>#药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87358, encryptionId=c0a18e35889, topicName=药品供应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c5232213503, createdName=yyanpro@32cn.c, createdTime=Tue Aug 14 22:34:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028719, encodeId=32f92028e19b3, content=<a href='/topic/show?id=dba72683e0b' target=_blank style='color:#2F92EE;'>#供应保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26837, encryptionId=dba72683e0b, topicName=供应保障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Sun Aug 19 00:34:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536325, encodeId=299c15363259e, content=<a href='/topic/show?id=ae8fe324387' target=_blank style='color:#2F92EE;'>#短缺药品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73243, encryptionId=ae8fe324387, topicName=短缺药品)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c7712689228, createdName=chaojitidian, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618007, encodeId=88b0161800e1f, content=<a href='/topic/show?id=c103e3239e8' target=_blank style='color:#2F92EE;'>#短缺药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73239, encryptionId=c103e3239e8, topicName=短缺药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1719824693, createdName=passed water, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628092, encodeId=2972162809271, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251982, encodeId=31c725198281, content=好啊后, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed Oct 11 16:45:04 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251958, encodeId=38dd2519589a, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Oct 11 14:08:06 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251927, encodeId=f6d025192e9b, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Wed Oct 11 13:14:53 CST 2017, time=2017-10-11, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1800932, encodeId=a12118009324a, content=<a href='/topic/show?id=f59ce3244d2' target=_blank style='color:#2F92EE;'>#短缺药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73244, encryptionId=f59ce3244d2, topicName=短缺药品供应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Dec 05 23:34:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716324, encodeId=704f1e16324b4, content=<a href='/topic/show?id=c0a18e35889' target=_blank style='color:#2F92EE;'>#药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87358, encryptionId=c0a18e35889, topicName=药品供应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c5232213503, createdName=yyanpro@32cn.c, createdTime=Tue Aug 14 22:34:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028719, encodeId=32f92028e19b3, content=<a href='/topic/show?id=dba72683e0b' target=_blank style='color:#2F92EE;'>#供应保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26837, encryptionId=dba72683e0b, topicName=供应保障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Sun Aug 19 00:34:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536325, encodeId=299c15363259e, content=<a href='/topic/show?id=ae8fe324387' target=_blank style='color:#2F92EE;'>#短缺药品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73243, encryptionId=ae8fe324387, topicName=短缺药品)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c7712689228, createdName=chaojitidian, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618007, encodeId=88b0161800e1f, content=<a href='/topic/show?id=c103e3239e8' target=_blank style='color:#2F92EE;'>#短缺药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73239, encryptionId=c103e3239e8, topicName=短缺药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1719824693, createdName=passed water, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628092, encodeId=2972162809271, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251982, encodeId=31c725198281, content=好啊后, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed Oct 11 16:45:04 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251958, encodeId=38dd2519589a, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Oct 11 14:08:06 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251927, encodeId=f6d025192e9b, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Wed Oct 11 13:14:53 CST 2017, time=2017-10-11, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1800932, encodeId=a12118009324a, content=<a href='/topic/show?id=f59ce3244d2' target=_blank style='color:#2F92EE;'>#短缺药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73244, encryptionId=f59ce3244d2, topicName=短缺药品供应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Dec 05 23:34:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716324, encodeId=704f1e16324b4, content=<a href='/topic/show?id=c0a18e35889' target=_blank style='color:#2F92EE;'>#药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87358, encryptionId=c0a18e35889, topicName=药品供应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c5232213503, createdName=yyanpro@32cn.c, createdTime=Tue Aug 14 22:34:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028719, encodeId=32f92028e19b3, content=<a href='/topic/show?id=dba72683e0b' target=_blank style='color:#2F92EE;'>#供应保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26837, encryptionId=dba72683e0b, topicName=供应保障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Sun Aug 19 00:34:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536325, encodeId=299c15363259e, content=<a href='/topic/show?id=ae8fe324387' target=_blank style='color:#2F92EE;'>#短缺药品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73243, encryptionId=ae8fe324387, topicName=短缺药品)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c7712689228, createdName=chaojitidian, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618007, encodeId=88b0161800e1f, content=<a href='/topic/show?id=c103e3239e8' target=_blank style='color:#2F92EE;'>#短缺药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73239, encryptionId=c103e3239e8, topicName=短缺药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1719824693, createdName=passed water, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628092, encodeId=2972162809271, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251982, encodeId=31c725198281, content=好啊后, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed Oct 11 16:45:04 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251958, encodeId=38dd2519589a, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Oct 11 14:08:06 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251927, encodeId=f6d025192e9b, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Wed Oct 11 13:14:53 CST 2017, time=2017-10-11, status=1, ipAttribution=)]
    2017-10-13 liuxiaona
  7. [GetPortalCommentsPageByObjectIdResponse(id=1800932, encodeId=a12118009324a, content=<a href='/topic/show?id=f59ce3244d2' target=_blank style='color:#2F92EE;'>#短缺药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73244, encryptionId=f59ce3244d2, topicName=短缺药品供应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Dec 05 23:34:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716324, encodeId=704f1e16324b4, content=<a href='/topic/show?id=c0a18e35889' target=_blank style='color:#2F92EE;'>#药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87358, encryptionId=c0a18e35889, topicName=药品供应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c5232213503, createdName=yyanpro@32cn.c, createdTime=Tue Aug 14 22:34:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028719, encodeId=32f92028e19b3, content=<a href='/topic/show?id=dba72683e0b' target=_blank style='color:#2F92EE;'>#供应保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26837, encryptionId=dba72683e0b, topicName=供应保障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Sun Aug 19 00:34:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536325, encodeId=299c15363259e, content=<a href='/topic/show?id=ae8fe324387' target=_blank style='color:#2F92EE;'>#短缺药品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73243, encryptionId=ae8fe324387, topicName=短缺药品)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c7712689228, createdName=chaojitidian, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618007, encodeId=88b0161800e1f, content=<a href='/topic/show?id=c103e3239e8' target=_blank style='color:#2F92EE;'>#短缺药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73239, encryptionId=c103e3239e8, topicName=短缺药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1719824693, createdName=passed water, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628092, encodeId=2972162809271, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251982, encodeId=31c725198281, content=好啊后, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed Oct 11 16:45:04 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251958, encodeId=38dd2519589a, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Oct 11 14:08:06 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251927, encodeId=f6d025192e9b, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Wed Oct 11 13:14:53 CST 2017, time=2017-10-11, status=1, ipAttribution=)]
    2017-10-11 有备才能无患

    好啊后

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1800932, encodeId=a12118009324a, content=<a href='/topic/show?id=f59ce3244d2' target=_blank style='color:#2F92EE;'>#短缺药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73244, encryptionId=f59ce3244d2, topicName=短缺药品供应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Dec 05 23:34:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716324, encodeId=704f1e16324b4, content=<a href='/topic/show?id=c0a18e35889' target=_blank style='color:#2F92EE;'>#药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87358, encryptionId=c0a18e35889, topicName=药品供应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c5232213503, createdName=yyanpro@32cn.c, createdTime=Tue Aug 14 22:34:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028719, encodeId=32f92028e19b3, content=<a href='/topic/show?id=dba72683e0b' target=_blank style='color:#2F92EE;'>#供应保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26837, encryptionId=dba72683e0b, topicName=供应保障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Sun Aug 19 00:34:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536325, encodeId=299c15363259e, content=<a href='/topic/show?id=ae8fe324387' target=_blank style='color:#2F92EE;'>#短缺药品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73243, encryptionId=ae8fe324387, topicName=短缺药品)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c7712689228, createdName=chaojitidian, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618007, encodeId=88b0161800e1f, content=<a href='/topic/show?id=c103e3239e8' target=_blank style='color:#2F92EE;'>#短缺药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73239, encryptionId=c103e3239e8, topicName=短缺药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1719824693, createdName=passed water, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628092, encodeId=2972162809271, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251982, encodeId=31c725198281, content=好啊后, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed Oct 11 16:45:04 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251958, encodeId=38dd2519589a, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Oct 11 14:08:06 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251927, encodeId=f6d025192e9b, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Wed Oct 11 13:14:53 CST 2017, time=2017-10-11, status=1, ipAttribution=)]
    2017-10-11 清风拂面

    很好的文章.谢谢分享

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1800932, encodeId=a12118009324a, content=<a href='/topic/show?id=f59ce3244d2' target=_blank style='color:#2F92EE;'>#短缺药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73244, encryptionId=f59ce3244d2, topicName=短缺药品供应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Dec 05 23:34:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716324, encodeId=704f1e16324b4, content=<a href='/topic/show?id=c0a18e35889' target=_blank style='color:#2F92EE;'>#药品供应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87358, encryptionId=c0a18e35889, topicName=药品供应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c5232213503, createdName=yyanpro@32cn.c, createdTime=Tue Aug 14 22:34:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028719, encodeId=32f92028e19b3, content=<a href='/topic/show?id=dba72683e0b' target=_blank style='color:#2F92EE;'>#供应保障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26837, encryptionId=dba72683e0b, topicName=供应保障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Sun Aug 19 00:34:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536325, encodeId=299c15363259e, content=<a href='/topic/show?id=ae8fe324387' target=_blank style='color:#2F92EE;'>#短缺药品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73243, encryptionId=ae8fe324387, topicName=短缺药品)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c7712689228, createdName=chaojitidian, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618007, encodeId=88b0161800e1f, content=<a href='/topic/show?id=c103e3239e8' target=_blank style='color:#2F92EE;'>#短缺药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73239, encryptionId=c103e3239e8, topicName=短缺药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d1719824693, createdName=passed water, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628092, encodeId=2972162809271, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Fri Oct 13 03:34:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251982, encodeId=31c725198281, content=好啊后, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed Oct 11 16:45:04 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251958, encodeId=38dd2519589a, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Oct 11 14:08:06 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251927, encodeId=f6d025192e9b, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Wed Oct 11 13:14:53 CST 2017, time=2017-10-11, status=1, ipAttribution=)]
    2017-10-11 1e0e5697m83(暂无匿称)

    henhao

    0

相关资讯

2017年“全国安全用药月”在京启动

10日上午,2017年“全国安全用药月”活动在北京启动,本次活动的主题为“安全用药,共享健康”。国家食品药品监督管理总局副局长孙咸泽出席启动仪式并致辞。

完善审评审批制度 加快急需药品和器械上市速度

国家食药监总局10月9日举行新闻发布会,介绍药品医疗器械审评审批改革鼓励创新工作有关情况,解读相关文件。

重磅!里程碑意义的文件印发 药品医疗器械审评审批改革深化

10月8日,中共中央办公厅和国务院办公厅联合印发《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》。

医院通知:药品返点40%!

昨日(10日),一份《桐城市人民医院关于药品带量采购返点的决议》(下称决议),在业界传开。文件显示:2017年10月9日,桐城市人民医院召开院长办公会议,专题研究了药品带量采购返点问题。

青岛57所公立医院全面取消药品加成

青岛市深入推进医药卫生体制改革,医疗卫生事业蓬勃发展,57所公立医院全面取消药品加成,居民主要健康指标处于全国前列并达到中等发达国家水平。

进口药品注册管理施行新规,官方解答六疑问

CFDA发布《关于调整进口药品注册管理有关事项的决定》,并就六大疑问给出官方答案。